Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron

Iron and its alloys have been widely used for variety of medical implants. These are used for long term applications as cheap implants with high inertness and low corrosion rate, and also as implants with high biocompatibility (the fourth-generation type). Such degrading implants can provide a tempo...

Full description

Bibliographic Details
Main Authors: Barak Menagen, David Avnir
Format: Article
Language:English
Published: IOP Publishing 2020-01-01
Series:Materials Research Express
Subjects:
Online Access:https://doi.org/10.1088/2053-1591/ab94fa
_version_ 1797746358228090880
author Barak Menagen
David Avnir
author_facet Barak Menagen
David Avnir
author_sort Barak Menagen
collection DOAJ
description Iron and its alloys have been widely used for variety of medical implants. These are used for long term applications as cheap implants with high inertness and low corrosion rate, and also as implants with high biocompatibility (the fourth-generation type). Such degrading implants can provide a temporary scaffold while the body heals. In addition to the needed mechanical support, it is highly desirable to provide local drug therapy, providing antibacterial properties, preventing rejection of the implant, and more. So far, the combination of a degradable metallic implant which serves also as a three-dimensional matrix for drug release, remained un-answered. Here we present, we believe for the first time realization of this concept: Entrapment of drugs within a 3D degradable metal matrix—iron—from which the entrapped drugs are sustain-released. This new type of material is based on the molecular metals entrapment materials methodology, resulting in drugs@Fe. Two drugs have been successfully entrapped and released: chlorhexidine - an antiseptic drug, and rapamycin—used for avoiding transplant rejection. The delivery profiles of the composites were studied in two forms—powders and pressed discs showing two different types of drug release profiles. The release of the drugs from the powder hasa first order release profile, while the pressed disk is a slower, zero-order release profile, which is highly desirable due to the constant rate of the release. Full characterization of the metallic biomaterials is provided, including XRD, SEM, TGA, elemental analysis, and surface area/porosity analysis.
first_indexed 2024-03-12T15:35:42Z
format Article
id doaj.art-bac594f7899940cb96c0197912b2f8fe
institution Directory Open Access Journal
issn 2053-1591
language English
last_indexed 2024-03-12T15:35:42Z
publishDate 2020-01-01
publisher IOP Publishing
record_format Article
series Materials Research Express
spelling doaj.art-bac594f7899940cb96c0197912b2f8fe2023-08-09T16:14:30ZengIOP PublishingMaterials Research Express2053-15912020-01-017606540410.1088/2053-1591/ab94faSustained release from biodegradable metallic matrix—The entrapment of drugs within ironBarak Menagen0https://orcid.org/0000-0002-0999-6479David Avnir1Institute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem , Jerusalem, 9190401, IsraelInstitute of Chemistry and the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem , Jerusalem, 9190401, IsraelIron and its alloys have been widely used for variety of medical implants. These are used for long term applications as cheap implants with high inertness and low corrosion rate, and also as implants with high biocompatibility (the fourth-generation type). Such degrading implants can provide a temporary scaffold while the body heals. In addition to the needed mechanical support, it is highly desirable to provide local drug therapy, providing antibacterial properties, preventing rejection of the implant, and more. So far, the combination of a degradable metallic implant which serves also as a three-dimensional matrix for drug release, remained un-answered. Here we present, we believe for the first time realization of this concept: Entrapment of drugs within a 3D degradable metal matrix—iron—from which the entrapped drugs are sustain-released. This new type of material is based on the molecular metals entrapment materials methodology, resulting in drugs@Fe. Two drugs have been successfully entrapped and released: chlorhexidine - an antiseptic drug, and rapamycin—used for avoiding transplant rejection. The delivery profiles of the composites were studied in two forms—powders and pressed discs showing two different types of drug release profiles. The release of the drugs from the powder hasa first order release profile, while the pressed disk is a slower, zero-order release profile, which is highly desirable due to the constant rate of the release. Full characterization of the metallic biomaterials is provided, including XRD, SEM, TGA, elemental analysis, and surface area/porosity analysis.https://doi.org/10.1088/2053-1591/ab94faironsustained releasebiodegradable implantsdrugsentrapment within metals
spellingShingle Barak Menagen
David Avnir
Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron
Materials Research Express
iron
sustained release
biodegradable implants
drugs
entrapment within metals
title Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron
title_full Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron
title_fullStr Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron
title_full_unstemmed Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron
title_short Sustained release from biodegradable metallic matrix—The entrapment of drugs within iron
title_sort sustained release from biodegradable metallic matrix the entrapment of drugs within iron
topic iron
sustained release
biodegradable implants
drugs
entrapment within metals
url https://doi.org/10.1088/2053-1591/ab94fa
work_keys_str_mv AT barakmenagen sustainedreleasefrombiodegradablemetallicmatrixtheentrapmentofdrugswithiniron
AT davidavnir sustainedreleasefrombiodegradablemetallicmatrixtheentrapmentofdrugswithiniron